SCHEMBL17767264

SCHEMBL17767264

C[C@@H]1C=C[C@H](C)[C@@](C)(CO)[C@]1(C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10702383 0.69 — —
SCHEMBL14325623 0.67 — —
SCHEMBL7114751 0.67 — —
SCHEMBL14325617 0.67 — —
SCHEMBL11007834 0.65 — —
SCHEMBL11007831 0.65 — —
SCHEMBL10869581 0.64 — —
SCHEMBL13850252 0.64 — —
SCHEMBL23193835 0.57 — —
SCHEMBL16569592 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4296365-A2 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. (US) 2023-12-27 — — EP disclosed
EP-3224368-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2023-10-25 — — EP disclosed
CN-107002104-B Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-08-17 — — CN disclosed
US-20210078966-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2021-03-18 — — US disclosed
CN-112279744-A Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-01-29 — — CN disclosed
US-10807963-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2020-10-20 — — US disclosed
US-20190169153-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2019-06-06 — — US disclosed
US-10208008-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2019-02-19 — — US disclosed
US-20160145227-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2016-05-26 — — US disclosed
Send feedback